$24.20
0.713.05%
Pre-Market: 7:39 PM EDT
15 minutes delayed
10x Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 10x Genomics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.32 | $-0.47 | 31.9 % |
Mar 2024 | 2024-04-30 | $-0.50 | $-0.50 | 0.00 % |
Dec 2023 | 2024-02-15 | $-0.24 | $-0.36 | 33.3 % |
Sep 2023 | 2023-11-02 | $-0.44 | $-0.46 | 4.35 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $153.10M | $150.74M | 1.57 % |
Mar 2024 | 2024-04-30 | $141.01M | $142.24M | -0.87 % |
Dec 2023 | 2024-02-15 | $183.98M | $182.80M | 0.64 % |
Sep 2023 | 2023-11-02 | $153.64M | $151.26M | 1.58 % |
10x Genomics (TXG) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.32, which beat the estimate of $-0.47.
The Actual Revenue was $153.1M, which beat the estimate of $150.7M.
Browse earnings estimates, EPS, and revenue on all stocks.